The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-31
DOI
10.3389/fimmu.2022.968799
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway
- (2022) Tianwei Zhang et al. ARCHIVES OF TOXICOLOGY
- Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers
- (2022) Melissa Dsouza et al. Cell Host & Microbe
- Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective
- (2022) Kylynda C. Bauer et al. GASTROENTEROLOGY
- Gut microbiota-derived ursodeoxycholic acid from neonatal dairy calves improves intestinal homeostasis and colitis to attenuate extended-spectrum β-lactamase-producing enteroaggregative Escherichia coli infection
- (2022) Zhiyuan He et al. Microbiome
- Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis
- (2022) Vali Musazadeh et al. Frontiers in Nutrition
- Risk assessment with gut microbiome and metabolite markers in NAFLD development
- (2022) Howell Leung et al. Science Translational Medicine
- A pilot study on the relationship between Lactobacillus, Bifidibactrium counts and inflammatory factors following exercise training
- (2021) Molanouri Shamsi Mahdieh et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Effects of Xylo-Oligosaccharides on Growth and Gut Microbiota as Potential Replacements for Antibiotic in Weaning Piglets
- (2021) Yuxia Chen et al. Frontiers in Microbiology
- Acetaldehyde Dehydrogenase 2 Regulates HMG-CoA Reductase Stability and Cholesterol Synthesis in the Liver
- (2021) Shanshan Zhong et al. Redox Biology
- The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine
- (2021) Deyang Yu et al. Cell Metabolism
- Amino acids-Rab1A-mTORC1 signaling controls whole-body glucose homeostasis
- (2021) Xin Zhang et al. Cell Reports
- FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption
- (2021) Bethan L. Clifford et al. Cell Metabolism
- A randomized, placebo-controlled trial investigating the acute and chronic benefits of American Ginseng (Cereboost®) on mood and cognition in healthy young adults, including in vitro investigation of gut microbiota changes as a possible mechanism of action
- (2021) Lynne Bell et al. EUROPEAN JOURNAL OF NUTRITION
- The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target
- (2021) Takaomi Kessoku et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients
- (2021) Nirja Mehta et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Bile acid dysmetabolism in the gut‐microbiota‐liver axis under hepatitis C virus infection
- (2021) Takako Inoue et al. LIVER INTERNATIONAL
- Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease
- (2021) Benjamin M. Scott et al. NATURE MEDICINE
- Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation
- (2021) Fengqi Hao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-fat diet–induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide
- (2021) Woongjae Yoo et al. SCIENCE
- Trimethylamine oxide: a potential target for heart failure therapy
- (2021) Shichao Lv et al. HEART
- A GLP‐1/GLP‐2 receptor dual agonist to treat NASH : Targeting the gut‐liver axis and microbiome
- (2021) Eun Ran Kim et al. HEPATOLOGY
- Unraveling the metabolic pathway of choline-TMA-TMAO: Effects of gypenosides and implications for the therapy of TMAO related diseases
- (2021) Qiao Zhang et al. PHARMACOLOGICAL RESEARCH
- Lithium carbonate alleviates colon inflammation through modulating gut microbiota and Treg cells in a GPR43-dependent manner
- (2021) Shengjie Huang et al. PHARMACOLOGICAL RESEARCH
- Preventive Effect and Molecular Mechanism of Lactobacillus rhamnosus JL1 on Food-Borne Obesity in Mice
- (2021) Mo Yang et al. Nutrients
- Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study
- (2021) Mary E. Rinella et al. JOURNAL OF HEPATOLOGY
- Fermentation Products of Commensal Bacteria Alter Enterocyte Lipid Metabolism
- (2020) João R. Araújo et al. Cell Host & Microbe
- Synbiotic Alters Fecal Microbiomes, but not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Non-alcoholic Fatty Liver Disease
- (2020) Eleonora Scorletti et al. GASTROENTEROLOGY
- Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?
- (2020) Judith Aron-Wisnewsky et al. GASTROENTEROLOGY
- Indole Alleviates Diet‐induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell PFKFB3
- (2020) Linqiang Ma et al. HEPATOLOGY
- Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity
- (2020) Ekaterina Smirnova et al. HEPATOLOGY
- Anti-Inflammatory and Anti-Oxidative Activity of Indole-3-Acetic Acid Involves Induction of HO-1 and Neutralization of Free Radicals in RAW264.7 Cells
- (2020) Yun Ji et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
- (2020) Tatsuo Kanda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
- (2020) Na Fei et al. mBio
- Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2020) Anika Nier et al. Nutrients
- Self-reinoculation with fecal flora changes microbiota density and composition leading to an altered bile-acid profile in the mouse small intestine
- (2020) Said R. Bogatyrev et al. Microbiome
- Branched-Chain Amino Acids Exacerbate Obesity-Related Hepatic Glucose and Lipid Metabolic Disorders via Attenuating Akt2 Signaling
- (2020) Huishou Zhao et al. DIABETES
- The Molecular and Mechanistic Insights Based on Gut–Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
- (2020) Yun Ji et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
- (2020) Xiang Zhang et al. GUT
- The Microbiome and Hepatocellular Carcinoma
- (2020) Puru Rattan et al. LIVER TRANSPLANTATION
- The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
- (2020) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer’s disease: a pre-clinical study
- (2020) Valentina Cecarini et al. Aging-US
- New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
- (2020) Domenico Ferro et al. Nutrients
- Using intestinal flora to distinguish non-alcoholic steatohepatitis from non-alcoholic fatty liver
- (2020) Chao Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome
- (2020) Oren Rom et al. Science Translational Medicine
- Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis
- (2019) Kai Schneider et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interactions between gut microbiota and non-alcoholic liver disease: the role of microbiota-derived metabolites
- (2019) Yufang Ding et al. PHARMACOLOGICAL RESEARCH
- Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice
- (2019) Bobae Kim et al. PLoS One
- Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematological malignancies carrying multidrug-resistance bacteria
- (2019) Giorgia Battipaglia et al. HAEMATOLOGICA
- A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma
- (2019) Federico Piñero et al. Annals of Hepatology
- Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
- (2019) Alison B. Evert et al. DIABETES CARE
- Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease
- (2019) Sara Carbajo-Pescador et al. Disease Models & Mechanisms
- The Beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content
- (2019) Yftach Gepner et al. JOURNAL OF HEPATOLOGY
- Trimethylamine N ‐Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease
- (2019) Xuying Tan et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats
- (2019) Ze-Hua Zhao et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease
- (2019) Karn Wijarnpreecha et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
- (2019) Ze-Hua Zhao et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Gut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention
- (2019) Yan Liu et al. Cell Metabolism
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress
- (2019) Yun Ji et al. Nutrients
- Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis
- (2019) Noemí Cabré et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Increased liver localization of lipopolysaccharides in human and experimental non‐alcoholic fatty liver disease
- (2019) Guido Carpino et al. HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain
- (2019) Kan Gao et al. Advances in Nutrition
- Lactobacillus accelerates ISCs regeneration to protect the integrity of intestinal mucosa through activation of STAT3 signaling pathway induced by LPLs secretion of IL-22
- (2018) Qihang Hou et al. CELL DEATH AND DIFFERENTIATION
- An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans
- (2018) Adil Mardinoglu et al. Cell Metabolism
- The Science of Obesity Management: An Endocrine Society Scientific Statement
- (2018) George A Bray et al. ENDOCRINE REVIEWS
- Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
- (2018) Phillipp Hartmann et al. HEPATOLOGY
- The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease–Like Ileitis
- (2018) Alexander Rodriguez-Palacios et al. INFLAMMATORY BOWEL DISEASES
- Update on FXR Biology: Promising Therapeutic Target?
- (2018) Chang Han INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans
- (2018) JACOB M. ALLEN et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
- (2018) Lesley Hoyles et al. NATURE MEDICINE
- Gut microbiota in adolescents and the association with fatty liver: the EPOCH study
- (2018) Maggie A Stanislawski et al. PEDIATRIC RESEARCH
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
- (2018) Chi Ma et al. SCIENCE
- Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice
- (2018) Jane M. Natividad et al. Nature Communications
- Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
- (2018) Mona Bafadhel et al. Lancet Respiratory Medicine
- The Microbiome and Metabolome of Preterm Infant Stool Are Personalized and Not Driven by Health Outcomes, Including Necrotizing Enterocolitis and Late-Onset Sepsis
- (2018) Stephen Wandro et al. mSphere
- A Prospective Metagenomic and Metabolomic Analysis of the Impact of Exercise and/or Whey Protein Supplementation on the Gut Microbiome of Sedentary Adults
- (2018) Owen Cronin et al. mSystems
- Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease
- (2018) Byron P. Vaughn et al. Clinical Gastroenterology and Hepatology
- Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model
- (2018) Soyoung Park et al. PLoS One
- Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels
- (2018) Jianzhong Ye et al. Frontiers in Microbiology
- Quantitative Analysis of the Whole-Body Metabolic Fate of Branched-Chain Amino Acids
- (2018) Michael D. Neinast et al. Cell Metabolism
- Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis
- (2018) Yasuhiko Sawada et al. HEPATOLOGY RESEARCH
- Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
- (2017) Fabiana de Faria Ghetti et al. EUROPEAN JOURNAL OF NUTRITION
- Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation
- (2017) David Porras et al. FREE RADICAL BIOLOGY AND MEDICINE
- Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
- (2017) Na Jiao et al. GUT
- Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
- (2017) Feng Shen et al. Hepatobiliary & Pancreatic Diseases International
- The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
- (2017) Puneet Puri et al. HEPATOLOGY
- Exogenous neutrophil elastase enters bronchial epithelial cells and suppresses cigarette smoke extract–induced heme oxygenase-1 by cleaving sirtuin 1
- (2017) Kyoung-Hee Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice
- (2017) Cheng Jun Jin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers
- (2017) Dong-Hyeon Kim et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Dual function of Lactobacillus kefiri DH5 in preventing high-fat-diet-induced obesity: direct reduction of cholesterol and upregulation of PPAR-α in adipose tissue
- (2017) Dong-Hyeon Kim et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Effects of Dietary Non-Fiber Carbohydrates on Composition and Function of Gut Microbiome in Monogastrics: A Review
- (2017) Hailong Jiang et al. PROTEIN AND PEPTIDE LETTERS
- Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier
- (2017) Da Zhou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- A study of the prebiotic-like effects of tomato juice consumption in rats with diet-induced non-alcoholic fatty liver disease (NAFLD)
- (2017) F. J. García-Alonso et al. Food & Function
- Alisol B 23-acetate induces autophagic-dependent apoptosis in human colon cancer cells via ROS generation and JNK activation
- (2017) Yueliang Zhao et al. Oncotarget
- In Vitro Antibacterial Activity of Unconjugated and Conjugated Bile Salts on Staphylococcus aureus
- (2017) Thippeswamy H. Sannasiddappa et al. Frontiers in Microbiology
- Gut Microbiota and IL-17A: Physiological and Pathological Responses
- (2017) Banafsheh Douzandeh-Mobarrez et al. Probiotics and Antimicrobial Proteins
- Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota
- (2017) Da Zhou et al. Scientific Reports
- Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation
- (2016) Qiang Meng et al. ACTA PHARMACOLOGICA SINICA
- Butyrate enhances antibacterial effects while suppressing other features of alternative activation in IL-4-induced macrophages
- (2016) Maria R. Fernando et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Interaction of gut microbiota with bile acid metabolism and its influence on disease states
- (2016) Christopher Staley et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial
- (2016) Dorien Reijnders et al. Cell Metabolism
- The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro
- (2016) Attilio Pingitore et al. DIABETES OBESITY & METABOLISM
- Formation of propionate and butyrate by the human colonic microbiota
- (2016) Petra Louis et al. ENVIRONMENTAL MICROBIOLOGY
- Gut microbiome and liver diseases
- (2016) Herbert Tilg et al. GUT
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- Small intestinal bacterial overgrowth is associated with non-alcoholic fatty liver disease
- (2016) Journal of Gastrointestinal and Liver Diseases
- From the Cover: Exposure to Oral Antibiotics Induces Gut Microbiota Dysbiosis Associated with Lipid Metabolism Dysfunction and Low-Grade Inflammation in Mice
- (2016) Yuanxiang Jin et al. TOXICOLOGICAL SCIENCES
- Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes
- (2016) Jill L Sherriff et al. Advances in Nutrition
- Systematic Review: Adverse Events of Fecal Microbiota Transplantation
- (2016) Sinan Wang et al. PLoS One
- Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
- (2016) Yu-ming Chen et al. Scientific Reports
- Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH)
- (2015) Cheng Jun Jin et al. BRITISH JOURNAL OF NUTRITION
- Gut–liver axis, nutrition, and non-alcoholic fatty liver disease
- (2015) Irina A. Kirpich et al. CLINICAL BIOCHEMISTRY
- Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation
- (2015) Gijs den Besten et al. DIABETES
- Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease
- (2015) Giovanni Tarantino et al. Future Microbiology
- Gut microbiota and non-alcoholic fatty liver disease
- (2015) Paraskevas Gkolfakis et al. Hepatobiliary & Pancreatic Diseases International
- Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease
- (2015) Shweta Kapil et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial
- (2015) Abbaszadeh Sepideh et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Elevation of branched-chain amino acid levels in diabetes and NAFL and changes with antidiabetic drug treatment
- (2015) Motoh Iwasa et al. Obesity Research & Clinical Practice
- Proteobacteria: microbial signature of dysbiosis in gut microbiota
- (2015) Na-Ri Shin et al. TRENDS IN BIOTECHNOLOGY
- Characterization and Detection of a Widely Distributed Gene Cluster That Predicts Anaerobic Choline Utilization by Human Gut Bacteria
- (2015) Ana Martínez-del Campo et al. mBio
- Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome
- (2015) Laurence Macia et al. Nature Communications
- The Role of Microbial Amino Acid Metabolism in Host Metabolism
- (2015) Evelien Neis et al. Nutrients
- Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease
- (2015) Sulin Cheng et al. PLoS One
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- (2014) Rifaat Safadi et al. Clinical Gastroenterology and Hepatology
- Biological significance of short-chain fatty acid metabolism by the intestinal microbiome
- (2014) Elena Puertollano et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
- (2014) Changtao Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Is serum Interleukin-17 associated with early atherosclerosis in obese patients?
- (2014) Giovanni Tarantino et al. Journal of Translational Medicine
- A single-component multidrug transporter of the major facilitator superfamily is part of a network that protectsEscherichia colifrom bile salt stress
- (2014) Stephanie Paul et al. MOLECULAR MICROBIOLOGY
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- Branched-chain amino acids in metabolic signalling and insulin resistance
- (2014) Christopher J. Lynch et al. Nature Reviews Endocrinology
- The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
- (2014) Pamela V. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota
- (2014) Y. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pleiotropic Roles of Bile Acids in Metabolism
- (2013) Thomas Q. de Aguiar Vallim et al. Cell Metabolism
- Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model
- (2013) P. Richards et al. DIABETES
- Western diet induces dysbiosis with increasedE coliin CEABAC10 mice,alters host barrier function favouring AIEC colonisation
- (2013) Margarita Martinez-Medina et al. GUT
- G Protein-Coupled Receptor 43 Moderates Gut Inflammation Through Cytokine Regulation from Mononuclear Cells
- (2013) Ryuta Masui et al. INFLAMMATORY BOWEL DISEASES
- Gut Microbiota, Low-grade Inflammation, and Metabolic Syndrome
- (2013) Benoit Chassaing et al. TOXICOLOGIC PATHOLOGY
- Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism
- (2012) Mitzi Dunagan et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
- (2012) Lixin Zhu et al. HEPATOLOGY
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
- Short chain fatty acids and their receptors: new metabolic targets
- (2012) Brian T. Layden et al. Translational Research
- Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats
- (2011) K.B.M. Saiful Islam et al. GASTROENTEROLOGY
- Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection
- (2010) Shawn A Ritchie et al. BMC Medicine
- Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice
- (2010) Soyoung Park et al. JOURNAL OF HEPATOLOGY
- A human gut microbial gene catalogue established by metagenomic sequencing
- (2010) Junjie Qin et al. NATURE
- Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
- (2010) Susan S. Baker et al. PLoS One
- Fecal bacteriotherapy for recurrent Clostridium difficile infection
- (2009) Johan S. Bakken ANAEROBE
- Acetaldehyde-induced mitochondrial dysfunction sensitizes hepatocytes to oxidative damage
- (2009) Blanca Eugenia Farfán Labonne et al. CELL BIOLOGY AND TOXICOLOGY
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance
- (2009) Christopher B. Newgard et al. Cell Metabolism
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started